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Ex vivo expanded haematopoietic progenitor cells improve
dermal wound healing by paracrine mechanisms
Abstract
BACKGROUND: Although dermal wounds are common, treatment remains limited and largely
ineffective. Recent studies suggest that therapeutic application of progenitor cells is useful for tissue
regeneration. OBJECTIVE: We here investigated the effects exerted by the recently characterized
immortalized haematopoietic progenitor cell line DKmix and their conditioned medium in a murine
wound healing model. METHODS AND RESULTS: Injection of both DKmix cells and their
conditioned medium accelerated wound repair between days 3 and 10 compared with PBS-injected
control mice (n = 8, P < 0.01 DKmix cells vs control, P < 0.01 conditioned medium vs control at day 6).
The treated groups exhibited more CD31(+)-capillaries at day 6 after injury compared with the control
group (n = 4, P < 0.01 DKmix cells vs control, P < 0.001 conditioned medium vs control), whereas there
was no change in infiltrated CD68(+) macrophages. Conditioned medium of DKmix cells induced tube
formation of human endothelial cells in Matrigel assays (n = 4-6, P < 0.05 conditioned medium vs
control) as well as migration (n = 4, P < 0.01 conditioned medium vs control) and proliferation of
murine 3T3 fibroblasts (n = 5, P < 0.05 conditioned medium vs control). Abundant levels of matrix
metalloproteinase -2 and -9 in the supernatants were detected. Protein arrays of the supernatants
revealed a strong secretion of cytokines and growth factors, such as monocyte chemoatractant protein-1
and GM-CSF from DKmix cells. CONCLUSION: DKmix cells improve skin-substitute wound healing
by promoting angiogenesis as well as migration and proliferation of fibroblasts. These data suggest that
immortalized haematopoietic progenitor cells significantly improve dermal wound healing by paracrine
effects.
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Abstract 
 
Background: Although dermal wounds are common, treatment remains limited and largely 
ineffective. Recent studies suggest that therapeutic application of progenitor cells are useful 
for tissue regeneration. 
Objective: We here investigated the effects exerted by the recently characterized 
immortalized hematopoietic progenitor cell line DKmix and their conditioned medium in a 
murine wound healing model. 
Methods and Results: Injection of both DKmix cells and their conditioned medium 
accelerated wound repair between day 3 to day 10 compared to PBS-injected control mice (n 
= 8, P<0.01 DKmix cells vs. control, P<0.01 conditioned medium vs. control at day 6). The 
treated groups exhibited more CD31+-capillaries at day 6 after injury compared to the control 
group (n = 4, P<0.01 DKmix cells vs. control, P<0.001 conditioned medium vs. control) 
whereas there was no change in infiltrated CD68+ macrophages. Conditioned medium of 
DKmix cells induced tube formation of human endothelial cells in Matrigel assays (n = 4-6, 
P<0.05 conditioned medium vs. control) as well as migration (n = 4, P<0.01 conditioned 
medium vs. control) and proliferation of murine 3T3 fibroblasts (n = 5, P<0.05 conditioned 
medium vs. control). Abundant levels of matrix metalloproteinase-2 and -9 in the supernatants 
were detected. Protein arrays of the supernatants revealed a strong secretion of cytokines and 
growth factors such as MCP-1 and GM-CSF from DKmix cells. 
Conclusion: DKmix cells improve skin-substitute wound healing by promoting angiogenesis 
as well as migration and proliferation of fibroblasts. These data suggest that immortalized 
hematopoietic progenitor cells significantly improve dermal wound healing by paracrine 
effects. 
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Introduction 
 
Wound repair is a tightly controlled process involving different cell types, cytokines, and 
extracellular matrix (ECM) reorganisation during three overlapping phases: The inflammatory 
phase (infiltration of cells which secrete cytokines and growth factors and assist in the 
removal of apoptotic cells and debris), the proliferative phase (tissue regeneration in response 
to initially produced factors) and the remodelling phase (regression of capillaries, ECM-
reorganization, and further maturation of the new tissue) [1]. Of note, cytokines and growth 
factors released at the wound site are essential for wound healing. In this regard, vascular 
endothelial growth factor (VEGF) has been shown to promote wound angiogenesis [2-4], 
monocyte chemoatractant protein (MCP)-1 is known to be involved in the recruitment of 
inflammatory cells into the wound [5] whereas interleukin (IL)-6 drives cell growth and 
differentiation [6]. Overall, efficient wound healing involves numerous factors, especially a 
sufficient supply of cytokines and growth factors [7] and adequate circulation of oxygenated 
blood. 
The transplantation of precursor cells has become a promising therapy for wound healing and 
repair of ischemic tissues, e.g. after myocardial infarction [8-10]. Recent studies have 
illustrated that precursors cells like bone marrow-derived stem cells [11-13], mesenchymal 
stem cells (MSCs) [14] and endothelial progenitor cells (EPCs) [15] participate in cutaneous 
wound healing and skin regeneration. Each cell type has its own advantages, limitations and 
practicability. In general, the relatively low number of stem and progenitor cells and their 
difficult of ex vivo expansion represent a major practical limitation, since high cell numbers 
are required for therapeutic application [16, 17]. Therefore, genetic modification of stem cells 
might be an option to expand these cells for therapeutic applications. In this regard, recent 
studies indicate an important role of the canonical Wnt/β-catenin signaling pathway to 
enhance stem cell survival and expansion prior to cell therapy. For example, it has been 
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shown that Wnt signaling promotes self-renewal of hematopoietic side populations, neuronal 
precursor cells, and embryonic stem cells [18-20]. Recently, we reported that retroviral 
mediated gene transfer of the constitutively active form of human β-catenin induces 
immortalization of murine hematopoietic progenitor cells (HPCs). This genetic modification 
results in the generation of a novel lineage-/Sca-1+/c-kit+ progenitor cell line referred to as 
DKmix cells [21]. This cell line is already maintained in culture for more than 3 years in our 
laboratory and comprises all morphological and phenotypical characteristics of HPCs. 
Furthermore, we showed that administration of DKmix cells after myocardial infarction 
reduces infarct size and improves left ventricle function and dimensions in a dose-dependent 
manner. This effect was associated with improved angiogenesis and reduced apoptosis in the 
infarct border zone [22]. 
The mechanisms by which stem and progenitor cells contribute to tissue regeneration and 
wound healing remain controversial. There are several reports that secreted cytokines and 
growth factors from stem and progenitor cells are critical for wound healing [3] in a paracrine 
manner. These factors have implications in local inflammation, re-epithelialization, 
granulation tissue formation, neovascularization, and production through multiple 
mechanisms [4]. The healing of a skin wound is a complex biological process, requiring a 
distinct collaboration of many different cells and tissues. Different experimental animal 
models have been established to study skin regeneration [23, 24]. In this study, we took 
advantage of a well-defined experimental murine model of dermal wound healing by 
mechanical application of a skin injury [15, 25]. In this model wound healing can be easily 
investigated by time-dependent monitoring of wound closure. The purpose of the present 
study was to investigate the effects of locally applied immortalized hematopoietic progenitor 
cells on dermal wound healing. Furthermore, we tested the hypothesis that progenitor cells 
exert their effects in this context mainly by paracrine secretion of soluble factors. 
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Methods 
 
Cell Culture 
The hematopoietic multipotent progenitor cell line DKmix was generated and characterized as 
described [21]. Briefly, human β-catenin cDNA was cloned into the retroviral vector SFβ-91-
IRES-eGFP, and recombinant VSV-G pseudotyped retroviruses were generated in the 
packaging cell line Phoenix-gp. Retroviral gene transfer into lin- cells was performed in the 
presence of a stem cell cytokine cocktail consisting of 10 ng/ml rmIL-3, 50 ng/ml rhIL-11, 50 
ng/ml rhFlt-3 and 50 ng/ml rmSCF (all from Cell Systems, St. Katharinen, Germany) over 48 
hours and transduced with a multiplicity of infection of 10 with 8 µg/ml polybrene (Sigma). 
DKmix was continuously cultured in suspension for more than 3 years in IMDM containing 
10% FCS, 2 mM L-Glutamine, 1 % Penicillin-Streptomycin, 1 mM Non-essential amino 
acids, 5 x 10-5 M 2-mercaptoethanol, 10 ng/ml rm-IL-3 and 50 ng/ml rm-SCF (all from Cell 
Systems, St. Katharinen, Germany). 
 
Flow cytometry 
Single cell suspensions were stained and examined on a BD FACSCalibur flow cytometer. 
Analysis was performed using CellQuest Pro software (BD Biosciences). The monoclonal 
antibodies against c-kit-APC, Sca-1-FITC were from BD Pharmingen. Cells were also stained 
with corresponding isotype-control antibodies. Fluorescence intensity plots are shown in log 
scales. 
 
Collection of Conditioned Medium 
Conditioned medium was generated as follows: DKmix cells were cultured in IMDM + 10% 
FCS for several days. After washing two times with serum free IMDM, cells were cultured in 
serum and additive free IMDM for an additional 12 h. Cells and medium were than harvested, 
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 7 
and cells were removed by centrifugation (1000 g, 10 min). For in vitro studies, we directly 
used the conditioned medium. 10%, 20% and 50% of conditioned medium was prepared by 
1:10, 1:5 and 1:2 dilutions with IMDM. For in vivo studies, we used supernatant from 1 x 107 
cells for each animal. After centrifugation (1000 g, 10 min), the supernatant was transferred 
into dedicated ultrafiltration tubes (Amicon Ultra-PL 5, Millipore, Bedford, MA, USA), 
concentrated 1:50 and diluted in PBS to a final volume of 200 µl. 
 
Animals and Dermal Wound Healing Model 
All animal experiments were approved by the local committee on animal research (509.6-
42502-03/686). The investigation conforms to the “Guide for the Care and Use of Laboratory 
Animals” published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996). To investigate the effect of DKmix cells and their conditioned medium on 
wound healing, male C57BL/6 mice (Charles River Laboratories), aged 12-14 weeks and 
weighing 20-22 g, were anesthetized with an intraperitoneal injection of a combination of 
ketamin (100mg/kg) and xylazine (1.25 mg/kg). After the dorsal surface of each mouse had 
been disinfected with an alcohol swab, a full-thickness excisional wound (0.5 cm in diameter) 
was created on the dorso-medial back of each animal, using a standard skin biopsy punch (5 
mm). Immediately after surgery, DKmix cells (1 x 107 cells in 200 µl of PBS), their 
conditioned medium (concentrated from 1 x 107 cells in 200 µl PBS) or PBS were injected 
subcutaneously around the wound at 8 different sites using a 1 mL syringe with a 30-gauge 
needle. The fluid was injected 1-2 mm deep, resulting in a subcutanous/intradermal edema 
surrounding the wound area. For control experiments, 1 x 107 cells labelled with 5-
carboxytetramethylrhodamine (5-TAMRA, Invitrogen, Carlsbad, CA) were injected. Wounds 
were considered as healed when the wound area was completely closed, the epithelial 
covering was restored, and the surface of the wound was smooth, homogeneous in colour, and 
without residual defects. 
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 8 
Analysis of Dermal Wound Sizes 
Each wound region was digitally photographed at the indicated time points, and wound areas 
were calculated using Corel Draw® software (version 12; Adobe Systems, San Jose, CA). 
The investigators measuring samples were blinded to group and treatment. Wound sizes at 
any given time point after wounding were expressed as percentage of initial wound area at 
day 0. Wounds were left uncovered and harvested with an 8 mm biopsy punch in mice 
cohorts of n = 8 per group at indicated time points. 
 
Statistical Analysis 
Data are presented as mean±SEM. Differences between groups were analyzed by Student`s t-
test followed by Bonferroni test. A p < 0.05 was considered to indicate statistical significance. 
 
Histological examination 
Mice were sacrificed by CO2 inhalation. Wounds with a margin of 2-3 mm of surrounding 
healthy tissue were excised, embedded in O.C.T. Tissue TEK (Sakura Finetek, Inc., Torrance, 
CA) and frozen in liquid nitrogen. For immunohistochemistry, each wound was trimmed from 
the border to about 1/3 of the total wound area. The following wound tissue directed to the 
centre of the wound was serially sectioned (6.0 µm thickness) perpendicular to the wound 
surface. Every 25th section (4 of each wound) in a distance of 150 µm was then subjected to 
immunohistochemistry. 
For the recovery of transplanted cells, sections were counterstained with DAPI and TAMRA-
labelled cells were identified by their immunofluorescence at 566 nm. 
Capillary density and macrophage content (n = 4 mice per group, two wounds per mouse) 
were determined by immunohistochemical staining with antibodies specific to CD31 (clone 
390, Serotec, Oxford, UK) and CD68 (clone FA-11, Serotec, Oxford, UK), respectively. 
Briefly, 6 µm sections were fixed in acetone for 15 min at room temperature, air dried, then 
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 9 
incubated briefly with 0,1% Tween20 (Sigma) in PBS, pretreated with 0,3% hydrogen 
peroxide, 10 mmol sodium azide in PBS to block endogenous peroxidase activity, and then 
blocked for non-specific protein binding with 5% BSA (Sigma) in PBS. Primary rat anti 
mouse CD31 and CD68 antibodies are diluted 1:200 in PBS with 1% BSA and applied on the 
sections for 60 minutes at room temperature. After washing 3 times (0,1% Tween in PBS) the 
secondary HRP labelled mouse anti rat IgG antibody (dianova, Hamburg, Germany) was 
incubated 30 minutes. Then the detected antigens have been visualized by incubation with 
ready to use AEC+ staining solution (DAKO, Hamburg, Germany). Finally, sections were 
counterstained with Mayers hematoxylin (Merck, Darmstadt. Germany) and mounted in 
aqueous Faramount mounting medium (DAKO, Hamburg, Germany). Image analysis 
software was utilized to determine capillary staining (Scion Image Software, Optronics 
Engineering Software). CD31- and CD68-positive area of the wound bed was assessed 
relative to the total wound bed area. Immunohistochemical staining was quantified in serial 
sections using a Leica DM 4000 B fluorescence microscope and Leica QWin V3.1 software. 
CD31- and CD68-positive area of the wound bed was assessed relative to the total wound bed 
area. Total wound bed area was defined by the marks caused by the standard skin biopsy 
punch in the epidermis up to subcutaneous occurrence of muscle fibers. In case of 
immunoflourescence Cy3 labelled goat anti rat IgG (Invitrogen) was used as a secondary 
antibody and sections have been sealed with Fluorescence mounting medium (DAKO, 
Hamburg, Germany). Flourecence was visualized with a TCS SP2 laser scanning spectral 
confocal microscope (Leica Microsystems). 
 
Matrigel Angiogenesis Assay In Vitro (Tube Formation) 
Human umbilical vein endothelial cells (HUVECs) were cultured in endothelial cell growth 
medium (EGM, PromoCell, Heidelberg, Germany) before being plated in 96-well plates (1 x 
104 cells per well) previously coated with 25 µL of Matrigel (growth factor-reduced; BD 
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Biosciences, San Diego, CA), in the presence of bFGF (100 ng/mL; CellSystems, St. 
Katharien, Germany) or supernatants from DKmix cells. Tube-like structures after 18 hours of 
culturing were visualized and quantified per well using an inverted cell culture microscope 
(magnification, 40 x; CKX31, Olympus, Hamburg, Germany) and a digital camera (C-5060, 
Olympus, Hamburg, Germany). 
 
Transwell Migration Assay 
3T3 fibroblasts (1 x 105) in 100 µl RPMI medium were placed in the upper chamber of 
Transwell cell culture inserts (8-µm pore size; Costar, Cambridge, MA). The lower chamber 
contained 600 µl RPMI supplemented with 10% FCS or supernatants from DKmix cells. 
Migration was carried out for 6 hours at 37°C, 5% CO2. Migrated cells into the lower 
chamber were quantified by counting in a Neubauer counting chamber using an inverted cell 
culture microscope (magnification, 100 x; CKX31, Olympus, Hamburg, Germany). 
 
Proliferation Assay 
3T3 fibroblasts were cultured in 96-well plates in RPMI medium containing 10% FCS to 
~50% confluence and maintained over night in RPMI medium without FCS. Cell proliferation 
after 16 hours was measured on the basis of DNA synthesis by 5-bromo-2’-deoxyuride 
(BrdU) incorporation in the presence of 10% FCS or supernatants from DKmix cells with a 
commercial colorimetric quantification kit (Roche, Mannheim, Germany) according to the 
manufacturer’s protocol. The amount of reaction product was determined by measuring the 
absorbance at 450 nm using a plate reader (µQuant, BIO-TEK, Bad Friedrichshall, Germany). 
 
Gelatine Zymography 
Supernatants from DKmix cells were separated by 10% SDS-PAGE supplemented with 1 
mg/mL gelatin. Recombinant mouse MMP-2 and MMP-9 was used as control. Gels were 
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renaturated by 2.5% Triton X-100 for 30 min, followed by a substrate buffer incubation (50 
mmol/L Tris/HCl, pH 7.5, containing 5 mmol/L CaCl2, 0.02% Brij-35) for 16h and stained 
with 0.5% Coomassie blue. Gelatinolytic activity was digitalized using a gel image analysis 
system (GeneGenius, Syngene, Cambridge, UK). 
 
Protein Array 
Supernatants from DKmix cells were analyzed using a commercial protein array for murine 
angiogenesis-related cytokines and growth factors (Eotaxin, Fas Ligand, bFGF, G-CSF, GM-
CSF, IFNγ, IGF-II, IL-1α, IL-1β, IL-12 p40/p70, IL-12 p70, IL-13, IL-6, IL-9, Leptin, MCP-
1, M-CSF, MIG, PF-4, TIMP-1, TIMP-2, TNFα, Thrombopoietin, VEGF; RayBiotech, 
Norcross, GA) according to the manufacturer’s instructions. Briefly, membranes were 
blocked for 30 min with blocking buffer and incubated with 1 mL of supernatants over night 
at 4°C. After washing biotin-conjugated antibody cocktail was added and again incubated 
over night at 4oC, followed by 2 hours incubation with streptavidin-conjugated peroxidase at 
room temperature. Membranes were incubated with peroxidase substrate and exposed to ECL 
films (Hyperfilm ECL, Amersham Bioscience, Heidelberg Germany). Films were digitalized 
and quantified densitometrically using a gel image analysis system (GeneGenius, Syngene, 
Cambridge, UK) and the software Quantity One (Bio-Rad, Hercules, CA). 
 
Enzyme-linked immunosorbent Assay (ELISA) 
Supernatants from DKmix cells were analyzed for MCP-1, IL-6, GM-CSF and VEGF levels 
using a commercial ELISA (R&D Systems, Minneapolis, MN) according to the 
manufacturer’s protocol. 
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Results 
 
Characterization of the Hematopoietic Progenitor Cell Line DKmix 
We recently described the generation of the hematopoietic progenitor cell line DKmix from 
lin- cells by retroviral transduction with β-catenin [21]. The cell line survived and proliferated 
in the presence of IL-3 and stem cell factor (SCF) for more than 3 years, whereas the viability 
of GFP transduced lin- control cells decreased dramatically after 22 days of culture. The β-
catenin transduced cells stably expressed the hematopoietic stem cell markers Sca-1 and c-kit 
(Figure 1) but failed to express lineage markers. The constitutive β-catenin expression was 
gradually down-regulated in DKmix cells during 40 weeks of culture through an unknown 
silencing mechanism [21]. In the present study, we used DKmix cells after 2 years of 
generation and culture. 
 
DKmix cells and their Conditioned Medium Accelerate Dermal Excisional Wound 
Healing 
The effects of transplantation of DKmix cells and their conditioned medium on wound 
healing were evaluated in a full-thickness excisional wound healing model in male C57BL/6 
wild type mice for up to 13 days. In control experiments, TAMRA-labelled DKmix cells 
could be easily detected at day 0, 2 and 6 demonstrating a good and persistent engraftment of 
the transplanted cells (Figure S1). However, as shown in Figure 2A and 2B, both DKmix cells 
and their conditioned medium accelerates the rate of wound closure significantly as early as 
day 3 after surgery, compared with PBS injection (DKmix cells = 25.9±2.6%, conditioned 
medium = 25.1±1.5%, PBS = 48.3±4.7%; % wound area of day 0). This reduction in wound 
size was observed until day 10 after wounding (DKmix cells = 2.6±0.5%, conditioned 
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medium = 0.5±0.2%, PBS = 7.5±1.5%; % wound area of day 0). We did not observe a 
significant difference in wound-closure rates among these groups at day 13. 
 
DKmix cells and their Conditioned Medium Enhance Wound Capillary Density 
Immunohistological staining of tissue sections for CD68-positive macrophages, as one wound 
inflammation marker, revealed no differences among the three groups at day 6 (Figure 3A). In 
contrast, endothelial cell-specific staining for CD31 showed increase capillary density in 
wounds treated with DKmix cells and their conditioned medium at day 6 compared to PBS 
treated wounds. As shown in Figure 3B, capillary density was significantly higher in DKmix 
cells treated wounds (5.60±0.52% of total wound area) and in wounds treated with the 
conditioned medium of DKmix cells (6.92±0.87% of total wound area) than in PBS treated 
wounds (3.03±0.38% of total wound area). 
 
Conditioned Medium from DKmix cells Enhances Angiogenesis as well as Migration 
and Proliferation of Fibroblasts in vitro 
We observed comparable effects on wound healing using DKmix cells or their conditioned 
medium suggesting that paracrine acting factors rather than cell-dependent effects promote 
wound tissue regeneration. Therefore we focused on the conditioned medium from DKmix 
cells to study the potential underlying regenerative mechanism. To investigate the effect of 
the conditioned medium on the angiogenic potential of endothelial cells, a Matrigel tube 
formation assay in vitro was employed using human endothelial cells (HUVECs). We 
observed a significant dose-dependent increase in the number of tube-like structures with 10% 
conditioned medium (16.7±3.3) which was even more pronounced with 20% (22.4±3.3) and 
50% (35.4±2.3) compared to unstimulated control (3.2±0.6) (Figure 4A). Since fibroblasts are 
crucially involved in dermal wound closure we investigated the influence of the conditioned 
medium from DKmix cells on fibroblast migration and proliferation in vitro. The migration of 
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murine 3T3 fibroblasts determined in Transwell inserts significantly increased in a dose-
dependent manner when stimulated with 10% (1.53±0.22-fold), 20% (1.75±0.16-fold) and 
50% conditioned medium (2.02±0.22-fold) compared to unstimulated control (Figure 4B). 
Likewise, we observed a dose-dependent effect of the conditioned medium on the cell 
proliferation of 3T3 fibroblasts. Proliferation was significantly enhanced with 10% 
(15,600±2,698 cells), 20% (18,975±1195 cells) and 50% conditioned medium (34,300±2,479 
cells) compared to unstimulated control (5,125±1,105) (Figure 4C) as measured by BrdU-
incorporation. 
 
DKmix cells secrete MMPs, cytokines and growth factors 
Since ECM-reorganisation in wound healing critically depends on the activities of proteases 
such as matrix metalloproteinases (MMPs) we performed gelatine zymography of the 
conditioned medium from DKmix cells. We could detect large amounts of pro-MMP-2 and 
pro-MMP-9 but also small amounts of the active form of both MMPs (Figure 5A). To 
examine potentially wound healing supporting cytokines and growth factors secreted by 
DKmix cells, we performed a commercially available protein array. Of note, we were able to 
detect most of the factors present on the array (Figure 5B). To confirm the data of the array 
and to obtain more quantitative data we performed ELISA assays for selected factors, such as 
MCP-1 (1017.6±153.8 pg/mL), IL-6 (70.5±1.3 pg/mL), GM-CSF (2.8±2.0 pg/mL) and VEGF 
(67.3±44.4 pg/mL). 
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Discussion 
 
Cell therapy for dermal wound healing requires sufficient numbers of defined and functional 
progenitor cells. In this regard, the role of transdifferentiation and potential paracrine effects 
is still unclear. Although HPCs have been shown to improve tissue regeneration, their use is 
currently limited by the low frequency of these cells in the bone marrow. Recently, we 
showed that β-catenin transduction of HPCs results in unlimited expansion of these cells 
(named DKmix cells) without loss of progenitor cell qualities [21]. 
Of course, there are numerous very attractive therapeutic targets in resident cells participating 
in the management of wound healing and remodeling. For instance, Ong and colleagues very 
recently identified an important role of the mammalian target of rapamycin (mTOR) in cell 
cycle regulation and ECM protein expression in fibroblasts [26]. However, in the current 
study we focused on HPC-mediated effects on wound healing. Therefore, we investigated the 
impact of DKmix cells and their conditioned medium on a cutaneous full-thickness excisional 
wound healing model in mice. Of note, we applied DKmix cells and their conditioned 
medium by eight injections into the remaining tissue closely to the wound margin [15, 25]. 
Technically, we favoured this application method over a direct injection into the new wound 
area to avoid a rapid washout of the cells and the medium. In addition, since dermal wound 
healing physiologically starts from the wound margin [1, 4] the chosen application method 
ensured a positioning of cells and factors directly at the origin of the healing process. 
Transplantation of DKmix cells and injection of their conditioned medium accelerated the rate 
of wound closure significantly as early as day 3 after surgery compared to PBS injected 
control mice. The reduction in wound size was observed until day 10 after wounding. This 
observation is in accordance with several recent studies, demonstrating accelerated rates of 
wound closure after transplantation of bone marrow derived stem cells [11], mesenchymal 
stem cells [14], EPC [15] and adipose-derived stem cells (ADSC) [27]. Remarkably, injection 
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of conditioned medium from DKmix cells revealed similar effects on wound healing rates in 
our study, indicating a substantial involvement of paracrine factors mediated by the 
transplanted DKmix cells. Cell-based paracrine effects have been well illustrated in 
cardiovascular disease models. For example, recent studies by Gnecchi et al. showed likewise 
that the intramyocardial injection of conditioned medium from MSCs significantly improves 
left ventricular cardiac function [28, 29]. These data supported the concept that the effect 
observed after intramyocardial injection of MSCs into infarcted hearts are to a great extent 
attributable to paracrine protection and functional recovery of ischemic myocardium. 
Furthermore, Kinnaird et al. showed that MSCs can contribute to collateral remodeling 
through paracrine mechanisms in a hind limb ischemia model [30]. 
In dermal wound healing models EPCs were shown to produce high levels of various chemo-
cytokines possibly mediating monocyte/macrophage recruitment as well as increased 
neovascularization [15]. Furthermore paracrine factors secreted from ADSC have been shown 
to act on fibroblast activation, migration and proliferation as well as on collagen synthesis, 
promoting accelerated wound healing [27]. 
Neovascularization is a crucial step in the wound healing process [4, 31, 32]. Analysis of 
neovascularization in the wounded tissue using the endothelial cell-specific marker CD31 
revealed a significant increased capillary density in wounds treated with DKmix cells and 
their conditioned medium at day 6 compared to PBS treated wounds. These data suggested 
that paracrine acting factors rather than cell-dependent effects promote wound tissue 
regeneration. Our observations are in accordance with recent studies, demonstrating pro-
angiogenic effects of EPCs, MSCs, ADSCs and their conditioned medium [15, 25, 27]. For 
example, Akt-overexpressing MSCs up-regulates the expression of several growth factors 
such as VEGF, FGF-2, HGF, IGF-1, and TB4 [28] known to be involved in pro-angiogenic, 
cardioprotective, and inotropic effects. A study by Wu et al. showed that differentiation of 
MSCs may be indispensable in MSC-mediated cutaneous repair. They suggest that MSCs 
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promote wound healing through differentiation and release of pro-angiogenic factors [25]. 
EPC incorporation into capillaries enhances neovascularization in EPC-treated mice. Besides 
differentiation of EPCs to mature endothelial cells this finding might be explained by that fact 
that EPCs secrete high levels of various angiogenic factors, such as VEGF and PDGF-BB, 
which might activate adjacent endothelial cells and further facilitate the formation of new 
blood vessels in wounded tissues [17, 33]. These studies and our data indicate a participation 
of paracrine effects, inducing the formation of new capillaries, which is necessary to sustain 
the newly formed granulation tissue and the survival of keratinocytes. Therefore, progenitor 
cell-mediated therapy as well as the application of progenitor cell-derived factors could be 
very useful for wound repair which requires functional vasculature to carry sufficient blood 
supply to meet massive local demands for fibroblast proliferation, extracellular matrix 
synthesis, and re-epithelialization. 
Contrary to wound angiogenesis we did not observe differences in the amounts of recruited 
CD68-positive macrophages into the wound between the groups at day 6. Therefore, our 
study suggests that a progenitor cell-based therapy did not enhance wound inflammation. This 
is in contrast to a study by Suh et al. which demonstrate that EPCs promote the recruitment of 
monocytes/macrophages into the wound [15]. These differences are maybe attributed to the 
different progenitor cell population used and to the secretion of a different pattern of paracrine 
acting factors, respectively. 
In vitro studies to the potential underlying regenerative mechanism of DKmix cells revealed a 
dose-dependent increase in endothelial tube formation as well as migration and proliferation 
of fibroblasts driven by their conditioned medium. We were able to detect several factors with 
reported regenerative potential in protein array experiments, such as VEGF, bFGF and GM-
CSF. This list is far away from being complete and it is tempting to speculate whether the 
observed effects in our study were mediated by few predominant factors or by a delicate 
balance of the whole cocktail. The identification and administration of defined cytokines and 
Page 17 of 32
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 18 
growth factors have certain theoretical advantages as a donor cell population for therapeutic 
applications. The direct application of high concentrations of proteins may circumvent host 
defects in progenitor cell recruitment or overcome growth factor deficiencies to improve 
wound healing rates. The use of autologous cells from diabetic patients may also be deficient 
in wound healing functions and therefore not suitable for therapeutic use. 
In conclusion, our study suggests that regenerative therapeutic potential of progenitor cells is 
still conserved in DKmix cells, which exert direct salutary effects on cutaneous wound 
healing via paracrine mediators. This is of particular interest since progenitor cells exit just in 
low frequency and the unlimited access on an ex vivo expansible cell line offers diverse 
therapeutic possibilities. The future identification of further secreted factors and their 
mechanism of action may have important implications on the development of novel molecular 
therapies for the healing of tissue damage. 
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Legends for illustrations 
 
Figure 1: Surface marker profile of the hematopoietic progenitor cell line DKmix. 
DKmix cells contain one main cell population (left panel). Lineage- cells (middle panel) were 
pre-gated on intact cells and were further analyzed for the stem cell marker antigen expression 
of Sca-1 and c-kit (>97% double positive cells) (right panel). Fluorescence intensity plots are 
shown in log scale. 
 
Figure 2: DKmix cells and their conditioned medium accelerate dermal excisional 
wound healing. 
(A) Representative images show wound healing in mice treated with PBS (control), DKmix 
cells or their conditioned medium at the indicated time points. Scale bar = 2 mm. 
(B) The wound sizes at any given time point after wounding were expressed as percentage of 
the initial wound at day 0 for PBS- (control), DKmix cells or with their conditioned medium- 
treated mice. Results are expressed as the mean±SEM (n = 8). *P<0.05 DKmix cells vs. 
control, **P<0.01 DKmix cells vs. control, DKmix cells, ##P<0.01 conditioned medium vs. 
control, §P<0.05 conditioned medium vs. DKmix cells. 
 
Figure 3: DKmix cells and their conditioned medium enhance wound capillary density. 
Histological examination of wound sections at day 6 after dermal excision for the macrophage 
marker CD68 (A) and for the endothelial cell-specific CD31 (B) (upper panels: 
immunohistochemical staining; lower panels: immunofluorescence). Scale bar = 200 µm. Bar 
graphs represent positive stained area of the wound relative to the total wound area as 
assessed by immunohistochemical staining. Results are expressed as the mean±SEM (n = 4 
mice per group, two wounds per mouse, four sections per wound), **P<0.01 DKmix cells vs. 
control, ##P<0.01 conditioned medium vs. control, n.s. = not significant. 
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Figure 4: Conditioned medium from DKmix cells enhances angiogenesis as well as 
migration and proliferation of fibroblasts in vitro. 
(A) Human endothelial cells (HUVECs) were cultured in Matrigel for 24 hours in the absence 
(control) and in the presence of conditioned medium from DKmix cells as indicated. 100 
ng/mL bFGF was used as positive control. Results are expressed as the mean±SEM (n = 4-6). 
*P<0.05 vs. control, **P<0.01 vs. control. 
(B) Migration of murine 3T3 fibroblasts was carried out in the absence (control) and in the 
presence of conditioned medium from DKmix cells as indicated. 10% FCS was used as 
positive control. Results are expressed as the mean±SEM (n = 4). *P<0.05 vs. control, 
**P<0.01 vs. control. 
(C) Proliferation of murine 3T3 fibroblasts was determined by BrdU incorporation in the 
absence (control) and in the presence of conditioned medium from DKmix cells as indicated. 
10% FCS was used as positive control. Results are expressed as the mean±SEM (n = 5). 
*P<0.05 vs. control, **P<0.01 vs. control. 
 
Figure 5: DKmix cells secrete MMPs, cytokines and growth factors. 
(A) Conditioned medium (CM) of DKmix cells was subjected to gelatine zymography (MM = 
MMP-2/-9 marker, PM = protein marker: 50 kDa, 75 kDa, 100 kDa). IMDM-medium (M) 
was used as negative control. One representative of four independent experiments is shown. 
(B) Top: Conditioned medium of DKmix cells was subjected to a commercial protein array 
for selected cytokines and growth factors. IMDM-medium was used as control. Below: 
Protein secretion was normalized to medium control and plotted relative to positive control. 
Results are expressed as the mean±SD (n = 3). b.t. = below threshold 
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Figure 5
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Supplementary Figure Legend
Figure S1: Engraftment of HPCs (DKmix)
Direct fluorescence microscopy of wound sections after intradermal delivery of TAMRA+
DKmix cells 0, 2 and 6 days after cell transfer. Blue: nuclei (DAPI), red: TAMRA+ DKmix
cells.
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